High Risk of Recurrence in Japanese Patients with HER2-Positive T1N0 Breast Cancer

被引：0
|
作者：
Tanaka, K. [1 ]
Kawaguchi, H. [1 ]
Koga, C. [1 ]
Nishimura, S. [1 ]
Yoshiyama, T. [1 ]
Yamaguchi, H. [1 ]
Nakamura, Y. [1 ]
Ohno, S. [1 ]
机构：
[1] Kyushu Natl Canc Ctr, Fukuoka, Japan
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P3-14-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-14-12
引用
收藏
页数：1
相关论文
共 50 条
  • [1] T1N0 Triple Negative Breast Cancer: Risk of Recurrence and Adjuvant Chemotherapy
    Kaplan, Henry G.
    Malmgren, Judith A.
    Atwood, Mary
    [J]. BREAST JOURNAL, 2009, 15 (05): : 454 - 460
  • [2] T1N0 triple negative breast cancer: adjuvant chemotherapy treatment and risk of recurrence
    Kaplan, H. H.
    Malmgren, J. A.
    Atwood, M. K.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S149 - S150
  • [3] Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
    Schroeder, Brock
    Zhang, Yi
    Stal, Olle
    Fornander, Tommy
    Brufsky, Adam
    Sgroi, Dennis C.
    Schnabel, Catherine A.
    [J]. NPJ BREAST CANCER, 2017, 3
  • [4] Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer
    Brock Schroeder
    Yi Zhang
    Olle Stål
    Tommy Fornander
    Adam Brufsky
    Dennis C. Sgroi
    Catherine A. Schnabel
    [J]. npj Breast Cancer, 3
  • [5] Effects of adjuvant trastuzumab with chemotherapy (ATWC) in T1N0 HER2 positive (HER2+) breast cancer.
    Kanjanapan, Yada
    Thomas, Susanna N.
    Yip, Desmond
    Dahlstrom, Jane E.
    Pathmanathan, Nirmala
    Craft, Paul Stanley
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Risk of Recurrence in Early-Stage, HER2-Positive Breast Cancer
    Isaacs, Claudine
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (08) : 3 - 6
  • [7] Significant increased recurrence rates among breast cancer patients with HER2-positive, T1a,bN0M0 tumors
    Rakkhit, R.
    Broglio, K.
    Peintinger, F.
    Cardoso, F.
    Hanrahan, E. O.
    Litton, J. K.
    Sahin, A.
    Larsimont, D.
    Meric-Bernstam, F.
    Buchholz, T. A.
    Valero, V.
    Theriault, R. L.
    Piccart, M.
    Ravdin, P.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 98S - 98S
  • [8] HER2 mutation status in Japanese HER2-positive breast cancer patients
    Endo, Yumi
    Dong, Yu
    Kondo, Naoto
    Yoshimoto, Nobuyasu
    Asano, Tomoko
    Hato, Yukari
    Nishimoto, Mayumi
    Kato, Hiroyuki
    Takahashi, Satoru
    Nakanishi, Ryoichi
    Toyama, Tatsuya
    [J]. BREAST CANCER, 2016, 23 (06) : 902 - 907
  • [9] HER2 mutation status in Japanese HER2-positive breast cancer patients
    Yumi Endo
    Yu Dong
    Naoto Kondo
    Nobuyasu Yoshimoto
    Tomoko Asano
    Yukari Hato
    Mayumi Nishimoto
    Hiroyuki Kato
    Satoru Takahashi
    Ryoichi Nakanishi
    Tatsuya Toyama
    [J]. Breast Cancer, 2016, 23 : 902 - 907
  • [10] Risk of local-regional and distant recurrence in triple-negative T1N0 breast cancer
    Malmgren, J. A.
    Atwood, M. K.
    Kaplan, H. G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345